IASO BioMed, Inc. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2018)

-$1.6M

Total Assets (FY2018)

$141.7K

Total Equity (FY2018)

-$602.5K

Cash Flows from Operating Activities (FY2018)

-$291.7K

Source: IASO BioMed, Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.